OCNDS was first identified in 2016. Due to its recent discovery, there is still much we don't know about this syndrome. This can be incredibly frustrating, particularly after receiving a life-altering diagnosis. We are making significant strides in understanding OCNDS thanks to the participation of our community in the Simons Searchlight Natural History Study and Ciitizen; however, to gain more insight, we need more participation from each and every family. As we gather more data and insights, we hope to provide answers to the many questions parents of children with OCNDS may have. See Family Research Opportunities to see how you can participate.
Every OCNDS parent is an expert in how this syndrome presents in their child, and sharing experiences and knowledge within our supportive community can be invaluable. We encourage caregivers to join our closed
Facebook group, where caregivers can connect with other parents facing similar challenges. Together, we can navigate the uncertainties of OCNDS and work towards a brighter future for our children.
The information provided is for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice.
Where indicated, “Parent response” denotes that a parent of a child with OCNDS provided this response and it does not necessarily represent the views of the foundation.
Yes, we have some families who passed down the mutation, and they also learned about their diagnosis because their child was diagnosed. There was a publication describing examples of this in 2023. You can see the research explained here.
Variants in the DNA change the instructions for making proteins. Pathogenic variants change important instructions in your DNA and are “disease-causing.”
We ask all families to register with the foundation here: https://www.csnk2a1foundation.org/contact-registry
We have a guideline published as a Gene Review. You can print it out and take it to your doctors, and they will see the guidelines and recommendations on what to do by each specialty.
For care recommendations, please see a simplified version of the Gene Review publication authored by Dr. Okur and Dr. Chung: https://www.csnk2a1foundation.org/OCNDS-gene-review
Dr. Chung talks about several things in this lecture: https://youtu.be/XuTz1D-WDu0.
We have started to collect information from families about their doctors. Please visit https://www.csnk2a1foundation.org/ocndsdoctors for a list of doctors recommended by the community. If you have a doctor you recommend, please submit their information here.
There is no specific ICD-10 code for OCNDS yet. It is an active goal of the foundation. We are applying for approval at the Fall 2024 meeting.
For insurance purposes, many people use Apraxia codes, developmental delay, and autism (if there is a diagnosis). For some families, the genetic diagnosis led to the utilization of code Q 99.9 “genetic defect” as a generic code. Prior to the OCNDS diagnosis, they just utilized other diagnosis- intellectual disability, stereotypy, etc.
Per a Simons Searchlight Survey in 2022, the symptoms with the greatest impact are:
This graphic highlights known OCNDS symptoms.
Symptoms of OCNDS Text Version
Brain
Muscle
GI
Face
Eye
Oral
Heart
Other
Some studies suggest that specific gene changes may yield distinct symptom profiles and/or severity levels. For example, see the research explained here. Additional studies are ongoing to investigate if changes in different parts of the gene cause specific symptom profiles.
The symptoms range from mild to severe regardless of the variant. Every child is unique in how the syndrome presents. There is some data to suggest that individuals with DNA changes that cause the protein not to be made may have a milder symptom profile than individuals who have missense mutations (where only one building block of the protein is replaced because of the mutation and the protein continues to be produced although its function is altered). You can learn more about this study by reading this research explained.
According to reports in the Simons Searchlight natural history study, Levetiracetam and Phenobarbital stood out as particularly effective for OCNDS patients.
Not everyone with OCNDS will develop seizures. Current estimates are between 25-33% of individuals with OCNDS that will develop seizures. As of April 2024, based on 23 individuals registered in Simons Searchlight natural history study, the age of seizure onset varied from 2 months to 16 years, with an average age of first seizure at 3.1 years, demonstrating wide variability across patients. As of April 2024, the most commonly reported seizure types are Petit mal and Grand mal seizures.
Headaches can be an underlying symptom of seizures.
Currently, the foundation does not have data to show that this is a symptom.
Parent response: For my child, these episodes were generally related to mucous draining (due to infection or just viral infection) or increased reflux. Once we had reflux more under control & less illness it got much better. She still has issues at times but has improved since she was younger.
She has also had issues with random vomiting which we linked to exposure to chlorine/pool chemicals in various pools irritating her asthma when she was younger.
Constipation is a common symptom reported in OCNDS. Approximately 63% of families in the Simons Searchlight natural history study report gastrointestinal issues.
Approximately 15% of OCNDS families in the Simons Searchlight natural history study report orthopedic issues (relating to the branch of medicine dealing with the correction of deformities of bones or muscles), including scoliosis (a spinal deformity that causes the spine to curve to the side, forming a C or S shape).
Approximately 10% of OCNDS families in the Simons Searchlight natural history study report joint problems.
Parent response: Our almost 11-year-old has what the Drs call crouch walk. She just got fitted with orthotics. She doesn’t talk much but I know her knees are hurting her because she keeps sitting down when walking.
Vision problems are common in patients with OCNDS and across neurodevelopmental syndromes. According to April 2024 updates from the Simons Searchlight natural history study, 37% of individuals with OCNDS experience astigmatism and 21% have crossed eyes.
Yes, speech delay is the most significant symptom of this syndrome and is considered a hallmark symptom of OCNDS. According to April 2024 updates from the Simons Searchlight natural history study, almost all (99%) of individuals with OCNDS have some level of language delay/impairment. The recommendation is to start speech therapy as early as possible. But it's never too late. It is also recommended to try other methods to develop a vocabulary. Try using communication technologies like an iPad, or other communication tools.
Data from the Simons Searchlight natural history study found that the top sleep problems in OCNDS are needing a parent in the room to sleep, restlessness/moving a lot, trouble sleeping away from the home, and not falling asleep within 20 minutes.
Families have reported using a variety of different interventions, including medications (melatonin, clonidine, hydroxyzine), other tools such as a weighted blanket, and methods such as co-sleeping. Some families found benefits by using a tent over the child’s bed for sensory blocking. Other families report using a therapeutic listening program through their occupational therapist. Other families who have children with OCNDS that have seizures noticed sleep improvements once seizure medications were started.
Yes. According to the April 2024 Simons Searchlight natural history study report, approximately 15% of individuals with OCNDS suffer from anxiety. Top behavioral concerns were impatience (ages 1.5-5 years) and obsessions (age 6-18 years). We have heard from families experiencing issues with self-injurious behaviors.
A new symptom diagnosed in individuals with OCNDS and autism is catatonia. Catatonia in autism is a complex condition marked by changes in movement, speech, and behavior. Symptoms include slowed speech, difficulty initiating tasks, freezing in place, unusual posturing, repetitive movements, and a decline in daily functioning. Some individuals may also exhibit self-injury or aggression, often triggered by frustration or difficulty responding to their environment. These symptoms can be mistaken for regression, leading to delays in recognition and treatment. Early intervention with behavioral strategies, medication, or electroconvulsive therapy (ECT) in severe cases can improve outcomes, making awareness and timely support crucial. To learn more about catatonia, you can watch this video by Dr. Josh Smith at Vanderbilt University: https://www.youtube.com/watch?v=JiOSKanKRfE
Parent response: What helped our situation was having an evaluation for depression and anxiety. Medication and therapy have helped. Finding other ways to cope instead of cutting is an ongoing process. This may sound silly, but we made a sensory box that has all things sensory in it, small treats, nail polish, face masks, small art projects etc. that we are constantly replenishing so when our daughter feels overwhelmed, she can use the box items to prevent cutting. It gives us something in the moment to direct her to and help her choose a different way to cope with overwhelming feelings. Visit https://www.crisistextline.org/topics/self-harm for more information.
We don’t have any specific study for this but we suggest contacting your child’s dentist as they may be ablet to help via use of a mouthpiece for the evenings. Another option would be to see a child psychiatrist to discuss anxiety management options.
The information provided is for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. We do not have any formal growth hormone studies that are ongoing, but we have heard of other children who have tried this therapy. This decision is between you and your endocrinologist. It might cause reaching the final adult height early, but on the other hand, it could help kids to grow who otherwise would have stunted growth. There are no known OCNDS-specific risks other than the general risks, and the benefits are the same as in any other growth hormone therapy when there is no growth hormone deficiency. We need to collect more information on this. For more information, you can view Dr. Chung’s presentation on growth hormone here. Please visit our research opportunities page to learn more.
Based on data in the Simons Searchlight natural history study, approximately 7% of individuals with OCNDS report immunodeficiency. Families have reported low values. Additionally, some families report getting IVIG (intravenous immunoglobulin) therapy with huge improvements.
We do not have enough data yet to determine if increased inflammatory markers are a symptom of OCNDS. We are aware that a subset of individuals with OCNDS experience immunodeficiency.
Most children with OCNDS begin missing milestones and are delayed in reaching milestones. Many have observed low muscle tone, feeding difficulties, breastfeeding difficulties, delayed motor skills such as crawling, pulling up and walking, and speech delay.
Data in the Simons Searchlight natural history study using data from 41 individuals with OCNDS highlights developmental changes using information from a standardized measure called the Vineland Adaptive Behavior Scales (Vineland-3). Some findings were:
See this summary for more details: https://docs.google.com/viewer?url=https%3A%2F%2Fcdn.simonssearchlight.org%2Fwp-content%2Fuploads%2F2023%2F08%2F15095642%2FCSNK2A1-23Q2-1.pdf
Parent response: Recommended underpants for not quite potty-trained kids (rare, small accidents): Max Shape (can purchase on Amazon). Maybe period underwear depending on size needed.
Parent response: There is a nose spray you can get. My daughter used it for years and helps the brain to detect that she needs to pee. You do 2 sprays one in each nostril and worked like a charm.
Parent response: Desmopressin link (DDAVP) is often the first choice of medicine for bedwetting. This medicine slows the amount of urine your child's body makes overnight, so the bladder doesn't overfill and leak. Desmopressin can work well, but bedwetting often returns when a child stops taking the medicine.
Currently, we don't have enough adult individuals with OCNDS to do follow-up studies. It can happen and emerge in individuals with neurodevelopmental syndromes that are caused by other genes. We can’t say there is no risk, but we also cannot say that there is a definite risk.
Currently, the oldest individual with OCNDS that we are aware of is 63.
We currently do not have enough information to provide an answer to this question. We hope to learn more about this through our natural history study.
This will vary depending on the individual. Every individual with OCNDS is different. The foundation knows of individuals living independently and holding jobs while others will require life-long care.
Please visit our website at https://www.csnk2a1foundation.org/guardianship for more information.
Parent response: There are businesses/organizations that work with the IDD community to help them get a driver's license. They also help when a person should not get a license. Most driver's license bureaus should be able to give you a local contact name.
Parent response: We had our older son take a defensive driving class. Your insurance person might also know of programs.
Parent response: In Australia there are occupational therapists who teach people with ID to drive. To prepare for the test, there might be an audio version of the driver's manual that your child can listen to while looking at it.
Parent response: My daughter took the class & driving test with the other kids and the instructor. I had to come in and read her the written test. She passed the test on the second try.
Helpful Videos
Parent response: My daughter does ABA therapy but we do a lot of ignoring attention-seeking behavior. At home we just go about the routine. School is harder and she tends to not have as many as before, but she gets put in “time out” which gives her the mental break she may need.
Parent response: I understand it can be frustrating when dealing with a non-neurotypical response and nervous system. Looking from our neurotypical perspective it might seem they are “laughing at discipline” but truly they may not cognitively or developmentally even understand the concept of discipline or be able to understand the concept of the discipline being related to their action.
Parent response: I disagree with ABA. It’s not for everyone. Most adult autistics that had ABA have nothing positive to report about their experience. This being said, I validate other parents’ opinions and don’t say that everyone should listen to me. So no meanness or disrespect meant to those that feel otherwise. I choose to listen to the adult autistic and disabled community who have experienced PTSD from behavioral therapies, and the many research studies that show it as ineffective. I have found a lot of value in Dr. Mona Delahooke’s books and approaches which are not focused on compliance vs. noncompliance but rather on the unique differences of Neuroception. Here is a good video that helps reframe the approach to behaviors: Importance of Respecting Individual Differences in the Context of Relationships- Dr. Mona Delahooke
There is a section in the Gene Reviews publication on ABA. Other than that, it’s usually better to be tailored to the individual kids’ needs, which is called an individual education plan. So, wherever the challenge is, the therapist would focus on that. We don't have anything specific that is recommended for neurodevelopmental disorders to be applied for kids with OCNDS.
Excerpt from the Gene Review publication:
ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and typically performed one on one with a board-certified behavior analyst.
Please see the following videos that may be helpful:
Parent response: We use an iPad to help with communication, and we use pictures also to help, and words are still coming out. We haven't given up hope, but my child has been in speech therapy five days a week since she was 18 months old. Don't give up hope. Keep trying.
Parent response: A lot of words with pictures and music, like associating words with the object. And some sign language. And things like directing attention to her mouth so he would watch the lips. Also, we used Baby bumblebee program. Which I HIGHLY recommend. www.babybumblebee.com/
Parent response: Music therapy is great, and it helped train his brain for speech.
Parent response: We started with basic sign language. Just the basics like drinking, eating, mommy and daddy. I think we need a lot more practice. He asks for a drink by making the drinking sign, but that's about it. I hoped it would be a way for him to communicate with us, but so far, he doesn't really use it. But you could give it a try, there are a lot of free apps that you can get to learn baby sign language.
Parent response:
Absolutely do it!
Parent response:
We taught
Parent response: We continued to use signs from a distance even once my daughter could talk. Helped to say when she was having difficulty in busy environments and when trying to interact with other children.... she could say if there was a problem with other children, without having to verbalize it.
Parent response: We’re in the UK and used children’s books about sign language and Mr. Tumble... the NHS also provided a 6-week makaton course... I found Mr. Tumble more useful though!
Parent response: My son did not start speaking till age 8 and sign was the best way for him to get his message across when we could not understand his words. I knew he understood the sign words when I took him to the fabric store at age 3 and he started signing “all done” repeatedly to get my attention. He is 18 now and signing from a distance or signaling to go to the bathroom is great to know.
Parent response: Our 2 girls have PT every week for an hour each child. Our 9-year-old is very delayed and didn't walk until 5. She now walks but is very unsteady and has balance problems. Their PT does a lot of fun stuff. Trampoline, riding bikes outside, playing ball, walking up and down stairs.
Parent response:
Parent response: PT went from a few times a week to currently one time a week. She has speech and OT 3 times a week now and has had this for a very long time now at 3 times a week. Her speech/language being the most concerning/delayed. PT - her gross motor skills falling not too far behind. We went through early intervention, to the public school and privately for everything. Lots of core strengthening, balancing, and working on everyday skills such as riding a bike (which she still cannot do by herself), balance beam, trampoline, swinging, jump rope, lifting small things, walking backwards etc.
Parent response:
Parent response: We're in the UK and our daughter received a multi-disciplinary approach - saw the physio, SLT and OT at the same time once every 3-6 months from the age of ~2. This continued until she started school at age 5. She eventually walked with a Walker (that we requested) and walked independently about age 4.5.
Parents have found the following therapies to be helpful.
Yes. To find out more about how you can participate in ongoing research, please visit https://www.csnk2a1foundation.org/family-research-opportunities
To read summaries of OCNDS research publications, please visit https://www.csnk2a1foundation.org/research-explained
Simons Searchlight Study Coordinators are always available to help families and participants with questions related to registration. Additionally, the Simons Searchlight team can help answer questions related to genetic lab reports, surveys, blood draws and more. They also address questions in their Facebook groups, but questions in the Facebook groups may not get answered as quickly as a direct email or phone call.
To learn more about why participating in the natural history study is important, please see this video by Dr. Chung. You can also watch a question-and-answer session here.
To learn how to generate a Simons Searchlight Account, please watch this video.
Email: coordinator@simonssearchlight.org
Phone: 1-855-329-5638
We are focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives.
CSNK2A1
Foundation is operated and funded through a committed team of volunteers, advocates and researchers.
We are a 501(c)(3) non-profit organization.
EIN #82-4220939.
Address: 1929 Van Ness Avenue, San Francisco, CA 94109
Phone:
(415) 501-0147
Email:
info@csnk2a1foundation.org
The information provided is not intended to be a substitute for professional medical advice, diagnosis or treatment. Never disregard professional medical advice, or delay in seeking it, because of something you have read on this website. Read more...
All Rights Reserved | CSNK2A1 Foundation